BioCentury
ARTICLE | Company News

Novo's R&D restructuring adds to innovation push

September 18, 2018 8:53 PM UTC

Four new R&D centers fueled by a dedicated business development unit and increased investment in machine learning and AI form the basis of an R&D restructuring announced by Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) on Tuesday.

The initiative is the latest step in a push begun by Novo in 2015 to find innovative therapies that add more value than those developed under its traditional approach of developing products with incremental improvements over existing therapies (see "Mountain Climbing")...

BCIQ Company Profiles

Novo Nordisk A/S